Journal articles on the topic 'Vaccine engineering'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Vaccine engineering.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Rizqoh, Debie. "Genetic Engineering Technique in Virus-Like Particle Vaccine Construction." Jurnal Kesehatan Masyarakat Indonesia 16, no. 4 (December 31, 2021): 203. http://dx.doi.org/10.26714/jkmi.16.4.2021.203-211.
Full textCasiño, Jenny J., and Angelo Mark P. Walag. "Issues and Challenges of, Factors that Affect, and the Primary Influences of Parents’ Decisions to Vaccinate their Adolescents: A Case of a Local National High School in Cagayan de Oro City, Philippines." Canadian Journal of Family and Youth / Le Journal Canadien de Famille et de la Jeunesse 14, no. 1 (January 1, 2022): 147–61. http://dx.doi.org/10.29173/cjfy29752.
Full textSchlotthauer, Felicia, Joey McGregor, and Heidi E. Drummer. "To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity." Viruses 13, no. 5 (April 30, 2021): 805. http://dx.doi.org/10.3390/v13050805.
Full textNuismer, Scott L., Benjamin M. Althouse, Ryan May, James J. Bull, Sean P. Stromberg, and Rustom Antia. "Eradicating infectious disease using weakly transmissible vaccines." Proceedings of the Royal Society B: Biological Sciences 283, no. 1841 (October 26, 2016): 20161903. http://dx.doi.org/10.1098/rspb.2016.1903.
Full textvan der Sanden, Sabine M. G., Weilin Wu, Naomi Dybdahl-Sissoko, William C. Weldon, Paula Brooks, Jason O'Donnell, Les P. Jones, et al. "Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game." Journal of Virology 90, no. 4 (November 18, 2015): 1694–704. http://dx.doi.org/10.1128/jvi.01464-15.
Full textOgonczyk Makowska, Daniela, Marie-Ève Hamelin, and Guy Boivin. "Engineering of Live Chimeric Vaccines against Human Metapneumovirus." Pathogens 9, no. 2 (February 19, 2020): 135. http://dx.doi.org/10.3390/pathogens9020135.
Full textVishweshwaraiah, Yashavantha L., and Nikolay V. Dokholyan. "Toward rational vaccine engineering." Advanced Drug Delivery Reviews 183 (April 2022): 114142. http://dx.doi.org/10.1016/j.addr.2022.114142.
Full textSudhakar, Poda, M. Usha Kiranmayi, Selvaraj Sankarpandian, Manyam Srinivasa Rao, M. Vijayalakshmi, and K. R. S. Sambasiva Rao. "Engineering generic vaccine vectors." International Journal of Biomedical Engineering and Technology 6, no. 1 (2011): 93. http://dx.doi.org/10.1504/ijbet.2011.040455.
Full textChoi, Ji Young, Bhushan Mahadik, and John P. Fisher. "3D printing technologies for in vitro vaccine testing platforms and vaccine delivery systems against infectious diseases." Essays in Biochemistry 65, no. 3 (August 2021): 519–31. http://dx.doi.org/10.1042/ebc20200105.
Full textTripp, Ralph, S. M. G. van der Sanden, W. Wu, N. dybdahl-Sissoko, William Weldon, P. Brooks, J. O'donnell, et al. "Engineering enhanced vaccine cell lines to eradicate vaccine preventable diseases: the polio endgame (VAC9P.1107)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 145.15. http://dx.doi.org/10.4049/jimmunol.194.supp.145.15.
Full textMarshall, Sarah, Anne C. Moore, Laura J. Sahm, and Aoife Fleming. "Parent Attitudes about Childhood Vaccines: Point Prevalence Survey of Vaccine Hesitancy in an Irish Population." Pharmacy 9, no. 4 (November 23, 2021): 188. http://dx.doi.org/10.3390/pharmacy9040188.
Full textAbu-Asab, Mones S., Majid Laassri, and Hakima Amri. "Algorithmic Assessment of Vaccine-Induced Selective Pressure and Its Implications on Future Vaccine Candidates." Advances in Bioinformatics 2010 (February 1, 2010): 1–6. http://dx.doi.org/10.1155/2010/178069.
Full textLaudi, Abby. "Identifying the Roles of Medical Providers when Addressing Barriers to HPV Vaccination Rates in Rural NE Clinics." Obstetrics Gynecology and Reproductive Sciences 6, no. 1 (January 5, 2022): 01–07. http://dx.doi.org/10.31579/2578-8965/093.
Full textShchelkunov, Sergey, and G. A. Shchelkunova. "Genes that control vaccinia virus immunogenicity." Acta Naturae 12, no. 1 (April 16, 2020): 33–41. http://dx.doi.org/10.32607/actanaturae.10935.
Full textFioretti, Daniela, Sandra Iurescia, Vito Michele Fazio, and Monica Rinaldi. "DNA Vaccines: Developing New Strategies against Cancer." Journal of Biomedicine and Biotechnology 2010 (2010): 1–16. http://dx.doi.org/10.1155/2010/174378.
Full textRenu, Sankar, Ashley D. Markazi, Santosh Dhakal, Yashavanth Shaan Lakshmanappa, Revathi Shanmugasundaram, Ramesh K. Selvaraj, and Gourapura J. Renukaradhya. "Engineering of Targeted Mucoadhesive Chitosan Based Salmonella Nanovaccine for Oral Delivery in Poultry." Journal of Immunology 200, no. 1_Supplement (May 1, 2018): 118.15. http://dx.doi.org/10.4049/jimmunol.200.supp.118.15.
Full textKashyap, Dharmendra, Mrutyunjaya Panda, Budhadev Baral, Nidhi Varshney, Sajitha R, Vasundhra Bhandari, Hamendra Singh Parmar, Amit Prasad, and Hem Chandra Jha. "Outer Membrane Vesicles: An Emerging Vaccine Platform." Vaccines 10, no. 10 (September 21, 2022): 1578. http://dx.doi.org/10.3390/vaccines10101578.
Full textCid, Raquel, and Jorge Bolívar. "Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies." Biomolecules 11, no. 8 (July 21, 2021): 1072. http://dx.doi.org/10.3390/biom11081072.
Full textNurunnabi, Abu Sadat Mohammad, Shamsi Sumaiya Ashique, Asmay Jahan, Afroza Akbar Sweety, and Saida Sharmin. "Children and COVID-19 Vaccine: A Public Health Ethics Perspective." Bangladesh Medical Journal 50, no. 3 (November 23, 2022): 44–48. http://dx.doi.org/10.3329/bmj.v50i3.62934.
Full textHerrera, Crystal M., Jessicia S. Schmitt, Erum I. Chowdhry, and Mark S. Riddle. "From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review." Vaccines 10, no. 5 (April 20, 2022): 645. http://dx.doi.org/10.3390/vaccines10050645.
Full textİsmail, Karakaş. "Plants That Can be Used as Plant-Based Edible Vaccines; Current Situation and Recent Developments." Virology & Immunology Journal 6, no. 3 (November 4, 2022): 1–10. http://dx.doi.org/10.23880/vij-16000302.
Full textLinhart, Birgit, and Rudolf Valenta. "Vaccine Engineering Improved by Hybrid Technology." International Archives of Allergy and Immunology 134, no. 4 (2004): 324–31. http://dx.doi.org/10.1159/000079535.
Full textPalca, Joseph. "Vaccine engineering: Violation of rules alleged." Nature 321, no. 6067 (May 1986): 190. http://dx.doi.org/10.1038/321190a0.
Full textO'Neill, Julia, George Atkins, Dan Curbison, Betsy Flak, James M. Lucas, Dana Metzger, Lindsay Morse, et al. "Statistical Engineering to Stabilize Vaccine Supply." Quality Engineering 24, no. 2 (April 2012): 227–40. http://dx.doi.org/10.1080/08982112.2012.654325.
Full textZagursky, Robert. "Vaccine discovery research by reverse engineering." Drug Discovery Today 8, no. 21 (November 2003): 972–73. http://dx.doi.org/10.1016/s1359-6446(03)02841-1.
Full textMukhtar, Mamuna, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi, and Naseeha Bibi. "Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches." International Journal of Molecular Sciences 23, no. 22 (November 11, 2022): 13911. http://dx.doi.org/10.3390/ijms232213911.
Full textWilson, Gavin, and Taiwo Aremu. "The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications." INNOVATIONS in pharmacy 13, no. 3 (October 18, 2022): 12. http://dx.doi.org/10.24926/iip.v13i3.5026.
Full textChavda, Vivek P., Md Kamal Hossain, Jayesh Beladiya, and Vasso Apostolopoulos. "Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena." Biologics 1, no. 3 (October 23, 2021): 337–56. http://dx.doi.org/10.3390/biologics1030020.
Full textKostina, L. V., A. D. Zaberezhnyy, T. V. Grebennikova, N. V. Antipova, T. I. Aliper, and E. A. Nepoklonov. "Vaccines against avian influenza in poultry." Problems of Virology, Russian journal 62, no. 2 (April 20, 2017): 53–60. http://dx.doi.org/10.18821/0507-4088-2017-62-2-53-60.
Full textMenon, Ipshita, Priyal Bagwe, Keegan Braz Gomes, Lotika Bajaj, Rikhav Gala, Mohammad N. Uddin, Martin J. D’Souza, and Susu M. Zughaier. "Microneedles: A New Generation Vaccine Delivery System." Micromachines 12, no. 4 (April 14, 2021): 435. http://dx.doi.org/10.3390/mi12040435.
Full textSuvvari, Tarun, Venkataramana Kandi, Divya Bala A. M. R. Salibindla, Simhachalam Kutikuppala, Christos Tsagkaris, and Venkata Narayana Nithish Modala. "Acceptance of COVID-19 Vaccine A mong Residents of South India: A Cross-sectional Survey." Perspectives in Medical Research 9, no. 3 (January 6, 2022): 72–78. http://dx.doi.org/10.47799/pimr.0903.17.
Full textCurrier, Arthur W., Madeline C. Jeshurin, and Valerie B. Sampson. "SARS-CoV-2 Targets and COVID-19 Vaccines." COVID 1, no. 3 (November 17, 2021): 608–21. http://dx.doi.org/10.3390/covid1030051.
Full textBavkar, Bhagyashri, Vaishali Gawade, Kanchan Wagh, and Sonali Dhuttargi. "Secured Quick Vaccine Manager: Smart Schedular, Tracker and Reminder using Cloud Technology." International Journal for Research in Applied Science and Engineering Technology 10, no. 5 (May 31, 2022): 3215–18. http://dx.doi.org/10.22214/ijraset.2022.43040.
Full textGraham, Barney S., Morgan S. A. Gilman, and Jason S. McLellan. "Structure-Based Vaccine Antigen Design." Annual Review of Medicine 70, no. 1 (January 27, 2019): 91–104. http://dx.doi.org/10.1146/annurev-med-121217-094234.
Full textKaushik, Nisha, Arti R. Thakkar, and K. Bangarurajan. "COVID-19 and Standardized Vaccines Development: A Brief Review." Journal of University of Shanghai for Science and Technology 23, no. 05 (May 19, 2021): 325–43. http://dx.doi.org/10.51201/jusst/21/05148.
Full textKim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. "In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen." Journal of Immunology 158, no. 2 (January 15, 1997): 816–26. http://dx.doi.org/10.4049/jimmunol.158.2.816.
Full textCastilho, Leda R., Nathalia R. Mattos, Wallace S. Abreu, and Melissa L. E. Gutarra. "Virus-Like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development." Biologics 2, no. 4 (October 31, 2022): 226–42. http://dx.doi.org/10.3390/biologics2040018.
Full textDuarte, Raiany Borges, Samara Moreira Felizarda, Mayra Parreira Oliveira, Júlia Martins Soares, Ísis Indaiara Gonçalves Granjeiro Taques, Raphaella Barbosa Meirelles-Bartoli, Dirceu Guilherme de Souza Ramos, and Ísis Assis Braga. "Persistence of vaccine immunity against canine parvovirus and canine distemper virus for determination of vaccine protocol in dogs: impacts and challenges in Brazil." Research, Society and Development 10, no. 11 (August 25, 2021): e127101119472. http://dx.doi.org/10.33448/rsd-v10i11.19472.
Full textMonreal-Escalante, Elizabeth, Abel Ramos-Vega, Carlos Angulo, and Bernardo Bañuelos-Hernández. "Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production." Vaccines 10, no. 1 (January 10, 2022): 100. http://dx.doi.org/10.3390/vaccines10010100.
Full textBhattacharya, Uma, and Mohit Nain. "A Comparative Analysis on the Doses of Covaxin and Covishield Vaccines Administered in India." International Journal for Research in Applied Science and Engineering Technology 10, no. 7 (July 31, 2022): 4431–43. http://dx.doi.org/10.22214/ijraset.2022.41654.
Full textVan Gilder, Deidra, and Shanna K. O'Connor. "Pharmacist Impact on Immunization Rates in Asplenic Patients." INNOVATIONS in pharmacy 13, no. 4 (November 17, 2022): 6. http://dx.doi.org/10.24926/iip.v13i4.4968.
Full textTurbhekar, Karan, and Aditya Srivastava. "Covid-19 Vaccination in India." International Journal for Research in Applied Science and Engineering Technology 10, no. 4 (April 30, 2022): 806–9. http://dx.doi.org/10.22214/ijraset.2022.41350.
Full textFaisol, Wildan, and Nizar Umar. "NASIONALISME VAKSIN SEBAGAI PRAKTIK NEOMERKANTILISME: ANALISA STUDI EKONOMI POLITIK INTERNASIONAL." Review of International Relations 4, no. 1 (July 4, 2022): 55–66. http://dx.doi.org/10.24252/rir.v4i1.27026.
Full textWalpita, Pramila. "Cell Derived Virus-Like Particles (VLP) in Future Vaccine Development." Vaccination Research – Open Journal 2, no. 1 (December 31, 2017): e1-e1. http://dx.doi.org/10.17140/vroj-2-e003.
Full textChen, Shuxiong, Diana H. Quan, Xiaonan T. Wang, Sarah Sandford, Joanna R. Kirman, Warwick J. Britton, and Bernd H. A. Rehm. "Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice." Nanomaterials 11, no. 8 (August 13, 2021): 2060. http://dx.doi.org/10.3390/nano11082060.
Full textPozniak, H. "Race for a vaccine [Engineering & Technology]." Engineering & Technology 15, no. 4 (May 1, 2020): 30–33. http://dx.doi.org/10.1049/et.2020.0402.
Full textFrietze, Kathryn M., David S. Peabody, and Bryce Chackerian. "Engineering virus-like particles as vaccine platforms." Current Opinion in Virology 18 (June 2016): 44–49. http://dx.doi.org/10.1016/j.coviro.2016.03.001.
Full textPurwito, Dedy. "From global to local action: rise from the pandemic, an efforts to increase routine immunization coverage." MEDISAINS 20, no. 1 (April 30, 2022): 1. http://dx.doi.org/10.30595/medisains.v20i1.13586.
Full textMasala, G. L., M. Lipsitch, C. Bottomley, and S. Flasche. "Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination." Journal of The Royal Society Interface 14, no. 136 (November 2017): 20170620. http://dx.doi.org/10.1098/rsif.2017.0620.
Full textFishman, Jordan, Leonard Moise, Pierre LeBlanc, Timothy Brauns, Eric Berg, Daniel Richer, Christine Boyle, et al. "VaxCelerate: the use of MTBhsp70-avidin as an adjuvant to rapidly generate self-assembling vaccines with biotinylated, antigen-specific peptides targeting emerging pathogens. (VAC6P.941)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 140.2. http://dx.doi.org/10.4049/jimmunol.192.supp.140.2.
Full text